Evidence map›Paper›PMID 40254835›Full record

ArticleBriefings in bioinformatics2025

Self-awareness of retrosynthesis via chemically inspired contrastive learning for reinforced molecule generation.

Yi Zhang, Jindi Huang, Xinze Li, Wenqi Sun, Nana Zhang, Jiquan Zhang, Tiegen Chen, Ling Wang

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yi ZhangGuangdong Provincial Key Laboratory of Fermentation and Enzyme Engineering, Joint International Research Laboratory of Synthetic Biology and Medicine, Guangdong Provincial Engineering and Technology Research Center of Biopharmaceuticals, School of Biology and Biological Engineering, South China University of Technology, No. 382 Waihuan East Road, Higher Education Mega Center, Guangzhou 510006, China.
Jindi HuangGuangdong Provincial Key Laboratory of Fermentation and Enzyme Engineering, Joint International Research Laboratory of Synthetic Biology and Medicine, Guangdong Provincial Engineering and Technology Research Center of Biopharmaceuticals, School of Biology and Biological Engineering, South China University of Technology, No. 382 Waihuan East Road, Higher Education Mega Center, Guangzhou 510006, China.
Xinze LiGuangdong Provincial Key Laboratory of Fermentation and Enzyme Engineering, Joint International Research Laboratory of Synthetic Biology and Medicine, Guangdong Provincial Engineering and Technology Research Center of Biopharmaceuticals, School of Biology and Biological Engineering, South China University of Technology, No. 382 Waihuan East Road, Higher Education Mega Center, Guangzhou 510006, China.
Wenqi SunGuizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, College of Pharmacy, Guizhou Medical University, No. 6 Ankang Avenue, Guian New District, Guiyang 561113, China.
Nana ZhangGuizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, College of Pharmacy, Guizhou Medical University, No. 6 Ankang Avenue, Guian New District, Guiyang 561113, China.
Jiquan ZhangGuizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, College of Pharmacy, Guizhou Medical University, No. 6 Ankang Avenue, Guian New District, Guiyang 561113, China.
Tiegen ChenZhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan Life Science Park, No. 10 Heqing Road, Tsui Hang New District, Zhongshan 528400, China.
Ling WangGuangdong Provincial Key Laboratory of Fermentation and Enzyme Engineering, Joint International Research Laboratory of Synthetic Biology and Medicine, Guangdong Provincial Engineering and Technology Research Center of Biopharmaceuticals, School of Biology and Biological Engineering, South China University of Technology, No. 382 Waihuan East Road, Higher Education Mega Center, Guangzhou 510006, China.

Funding

National Natural Science Foundation of China 81973241Natural Science Foundation of Guangdong Province 2020A1515010548
6 · The paper itself

Abstract

The recent progress of deep generative models in modeling complex real-world data distributions has enabled the generation of novel compounds with potential therapeutic applications for various diseases. However, most studies fail to optimize the properties of generated molecules from the perspective of the intrinsic nature of chemical reactions. In this work, we propose a novel molecule generation model to overcome the limitation by deep reinforcement learning, in which an agent learns to optimize the properties of molecules initialized with a chemically inspired contrastive pretrained model. We finally assess the generation model by evaluating its ability to generate inhibitors against two prominent therapeutic targets in cancer treatment. Experimental results show that our model could generate 100% valid and novel structures and also exhibits superior performance in generating molecules with fewer structural alerts against several baselines. More importantly, the molecules generated by our proposed model show potent biological activities against ataxia telangiectasia and Rad3-related (ATR) and cyclin-dependent kinase 9 (CDK9) targets in wet-lab experiments.

Indexed as

Deep LearningDrug DesignATR inhibitorCDK9 inhibitorcontrastive learningdrug discoverymolecule generation

Identifiers

PMID40254835
PMCPMC12009711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.